TRACON Pharmaceuticals Inc (NASDAQ:TCON) announced results from a clinical trial that combined its Inlyta product with TRC105 to treat patients that suffer…

Apricus Biosciences Inc (NASDAQ:APRI) completed a direct offering valued at $11 million. The agreement is with Sarissa Capital management and another accredited…

Second Sight Medical Products Inc (NASDAQ:EYES) announced that is has completed its first successful implants procedure. The three centers currently approved…

Biocept Inc (NASDAQ:BIOC) made public that its OncoCEE-BR drug in a prospective study performed at Columbus University. The drug is a blood-based diagnostic…

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is closing on a deal to acquire bowel drug maker Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) for $160 a share….

HCA Holdings Inc (NYSE:HCA) awaits to see the final verdict from the Supreme Court that is expected to have huge ramification on the Affordable Care Act….

Stereotaxis Inc (NASDAQ:STXS) announced that it has passed 75,000 procedures using its Stereotaxis remote magnetic navigation technology. The technology…

CorMedix Inc. (NYSEMKT:CRMD) announced its lead product, Neutrolin Catheter Lock Solution, has received the Food and Drug Administrations Qualified Infectious…

Egalet Corp (NASDAQ:EGLT) made public the results from its Category 3 human abuse liability study of Egalet-100 showed positive results for severe pain…